All stock lists
Actuate Therapeutics, Inc. (NASDAQ:ACTU)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.50
Insider Score
––Not scored
ACTU Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ACTU Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.84 M | 3.14 M | 2.56 M | 3.29 M | 3.20 M | 3.15 M |
| R&D Expense | 2.07 M | 2.57 M | 2.13 M | 2.18 M | 2.76 M | 3.22 M |
| Operating Expenses | 4.91 M | 5.71 M | 4.69 M | 5.47 M | 5.97 M | 6.37 M |
| Operating Income | -4.91 M | -5.71 M | -4.69 M | -5.47 M | -5.97 M | -6.37 M |
| Pretax Income | -4.87 M | -5.63 M | -4.55 M | -5.41 M | -5.95 M | -6.32 M |
| Tax Provision | 0.00 | 0.00 | 800.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -4.87 M | -5.63 M | -4.55 M | -5.41 M | -5.95 M | -6.32 M |
| EPS (Basic) | -0.20 | -0.24 | -0.20 | -0.25 | -0.30 | -0.32 |
| EPS (Diluted) | -0.20 | -0.24 | -0.20 | -0.25 | -0.30 | -0.32 |
| Shares Outstanding | 23.87 M | 23.54 M | 23.25 M | 21.39 M | 19.65 M | 19.50 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.